The SARS-CoV-2 virus shares 79.6% sequence identity with SARS-CoV and reaches the cell using the same receptor, angiotensin, which is converted to enzyme II (ACE2).
News
On this page, Orya Medikal company information articles and articles related to treatments are published. You can follow our page for up-to-date information.
0216 383 26 76
ORYA MEDİKAL
Orya Medikal started to give services related to Cardiology, Cardiovascular and Newborn departments in the health sector in 2007 and has adopted the principle of producing and serving the specific products that the sector needs.